Yoga for the Management of HIV-Metabolic Syndromes
瑜伽治疗艾滋病毒代谢综合症
基本信息
- 批准号:7140085
- 负责人:
- 金额:$ 22.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS therapyHIV infectionsadipose tissuealternative medicineantiAIDS agentbody compositioncardiovascular disorder riskcardiovascular functionclinical researchfibrinolysisglucose toleranceglucose tolerance testhelper T lymphocytehuman subjecthuman therapy evaluationinflammationinsulin sensitivity /resistanceleukocyte countlifestylemagnetic resonance imagingmedical complicationmeditationmetabolic syndromeoxygen consumptionpatient oriented researchphoton absorptiometry
项目摘要
DESCRIPTION (provided by applicant): The introduction of highly active antiretroviral therapy (HAART) has dramatically improved quality of life, and substantially reduced morbidity and mortality rates for people living with HIV. But, HIV-infection and HAART have been associated with a cluster of metabolic and anthropomorphic syndromes (HIV-metabolic syndrome; HIV+MS) that jeopardize long-term cardiovascular disease (CVD) risk profiles for people living with HIV. The cause of these complications is multifactorial. Few safe and effective traditional treatments (drugs, changing anti-HIV medications) have been identified. The ancient practice of a Yoga lifestyle has been re-popularized as a complementary, non-traditional treatment for metabolic, anthropomorphic, and cardiovascular disorders. Yoga provides integrated control and harmonious balance among eating habits, exercise, rest, breathing style, and the mind-body relationship through the practice of postures, muscle contraction, controlled breathing, and meditation. Holistic balance among physiologic processes provides relief from disease. We propose to objectively examine the safety and efficacy of a yoga lifestyle intervention in 26 women and 26 men infected with HIV, treated with HAART and experiencing metabolic syndromes that increase CVD risk. We hypothesize that a yoga lifestyle intervention will be safe and enhance (complement) the benefits of standard-of-care therapy for HIV+MS. Participants will be randomly assigned to continue standard-of-care therapy, or add a supervised yoga lifestyle intervention to standard-of-care therapy. Yoga lifestyle intervention will be taught and supervised by trained and experienced yoga instructors employed by Living By Design Inc., a St. Louis-based healthcare program that provides complementary and alternative rehabilitative therapies to people living with HIV (and other chronic disorders). Standardized and objective measurements of oral glucose tolerance, insulin sensitivity, serum lipid/lipoprotein levels, serum markers of fibrinolysis and inflammation, adipose tissue distribution, cardiovascular function and CVD risk will be quantified before and at the end of 4-months of therapy. Yoga lifestyle practices have not been objectively tested in the management of HIV+MS, and may offer an inexpensive, safe, effective and easy to adhere to alternative management strategy for a chronic infection with lifelong implications for CVD and other health risks.
描述(由申请人提供):引入高度活跃的抗逆转录病毒疗法(HAART)已大大改善了生活质量,并大大降低了HIV患者的发病率和死亡率。但是,HIV感染和HAART与一群代谢和拟人化综合征(HIV代谢综合征; HIV+MS)有关,危害了患有HIV患者的长期心血管疾病(CVD)风险特征。这些并发症的原因是多因素。很少发现安全有效的传统治疗方法(药物,改变的抗HIV药物)。瑜伽生活方式的古老实践已被重新占据,作为一种互补的,非传统的治疗方法,用于代谢,拟人化和心血管疾病。瑜伽在饮食习惯,运动,休息,呼吸风格以及通过姿势,肌肉收缩,控制呼吸和冥想的实践中提供综合的控制和和谐平衡。生理过程之间的整体平衡可缓解疾病。我们建议客观地检查对26名女性和26名感染HIV的男性的瑜伽生活方式干预的安全性和功效,并接受了HAART治疗,并经历了增加CVD风险的代谢综合症。我们假设瑜伽生活方式干预将是安全的,并增强(补充)护理标准疗法对HIV+MS的好处。参与者将被随机分配以继续护理标准疗法,或在护理标准疗法中添加监督的瑜伽生活方式干预。 Live By Design Inc.雇用的训练有素且经验丰富的瑜伽教练将教授和监督瑜伽生活方式干预,这是一项总部位于圣路易斯的医疗保健计划,为艾滋病毒(和其他慢性疾病)提供补充和替代性康复治疗。口服葡萄糖耐量,胰岛素敏感性,血清脂质/脂蛋白水平,纤维蛋白溶解和炎症的血清标记,脂肪组织分布,心血管功能和CVD风险的标准化和客观测量。瑜伽生活方式实践尚未在HIV+MS的管理中进行客观测试,并且可能会提供廉价,安全,有效且易于遵守替代管理策略,以造成长期感染,对CVD和其他健康风险产生终生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEVIN E YARASHESKI其他文献
KEVIN E YARASHESKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEVIN E YARASHESKI', 18)}}的其他基金
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTS
瑜伽生活方式干预可降低感染艾滋病毒的成年人的血压
- 批准号:
8361436 - 财政年份:2011
- 资助金额:
$ 22.41万 - 项目类别:
MYOCARDIAL INSULIN RESISTANCE IS NOT WORSENED BY WELL-CONTROLLED HIV INFECTION
心肌胰岛素抵抗不会因 HIV 感染得到良好控制而恶化
- 批准号:
8361470 - 财政年份:2011
- 资助金额:
$ 22.41万 - 项目类别:
ISOTOPE RATIO MASS SPECT IN HUMAN BIOLOGY AMINO ACID METABOLISM & KINETICS
人类生物学氨基酸代谢中的同位素比质谱
- 批准号:
7721443 - 财政年份:2008
- 资助金额:
$ 22.41万 - 项目类别:
EXERCISE AND PIOGLITAZONE FOR HIV-METABOLIC SYNDROMES
运动和吡格列酮治疗艾滋病毒代谢综合征
- 批准号:
7721457 - 财政年份:2008
- 资助金额:
$ 22.41万 - 项目类别:
CHARACTERIZING THE HIV MUSCLE MITOCHONDRIAL PROTEOME
HIV 肌肉线粒体蛋白质组的特征
- 批准号:
7721452 - 财政年份:2008
- 资助金额:
$ 22.41万 - 项目类别:
CHARACTERIZING THE AGING MUSCLE MITOCHONDRIAL PROTEOME
表征衰老肌肉线粒体蛋白质组
- 批准号:
7721481 - 财政年份:2008
- 资助金额:
$ 22.41万 - 项目类别:
MYOCARDIAL FUNCTION AND FFA METABOLISM IN HIV-METABOLIC SYNDROME
HIV 代谢综合征中的心肌功能和 FFA 代谢
- 批准号:
7603362 - 财政年份:2007
- 资助金额:
$ 22.41万 - 项目类别:
EXERCISE AND PIOGLITAZONE FOR HIV METABOLIC SYNDROMES
运动和吡格列酮治疗艾滋病毒代谢综合征
- 批准号:
7603337 - 财政年份:2007
- 资助金额:
$ 22.41万 - 项目类别:
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMES
瑜伽治疗艾滋病毒代谢综合征
- 批准号:
7603354 - 财政年份:2007
- 资助金额:
$ 22.41万 - 项目类别:
REDUCING PLASMA HIV RNA IMPROVES MUSCLE AMINO ACID METABOLISM
减少血浆 HIV RNA 改善肌肉氨基酸代谢
- 批准号:
7355251 - 财政年份:2006
- 资助金额:
$ 22.41万 - 项目类别:
相似国自然基金
艾滋病毒感染后疾病进展和治疗的动力学模型与研究
- 批准号:10971163
- 批准年份:2009
- 资助金额:26.0 万元
- 项目类别:面上项目
用细菌传递RNA干扰经肠道黏膜免疫系统治疗艾滋病毒感染
- 批准号:30972624
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
艾滋病毒感染病者口腔疣状肿块的细胞生物学特性
- 批准号:30660199
- 批准年份:2006
- 资助金额:20.0 万元
- 项目类别:地区科学基金项目
HIV-1 tat 蛋白及其相互作用的细胞因子功能性研究
- 批准号:30570069
- 批准年份:2005
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
The Gut-Liver Axis in HIV-Related Non-Alcoholic Fatty Liver Disease
HIV 相关非酒精性脂肪肝中的肠肝轴
- 批准号:
10762284 - 财政年份:2023
- 资助金额:
$ 22.41万 - 项目类别:
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
雌激素替代对绝经后 ART 相关合并症和病毒潜伏期的影响
- 批准号:
10326734 - 财政年份:2021
- 资助金额:
$ 22.41万 - 项目类别:
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
雌激素替代对绝经后 ART 相关合并症和病毒潜伏期的影响
- 批准号:
10468267 - 财政年份:2021
- 资助金额:
$ 22.41万 - 项目类别:
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
雌激素替代对绝经后 ART 相关合并症和病毒潜伏期的影响
- 批准号:
10624286 - 财政年份:2021
- 资助金额:
$ 22.41万 - 项目类别:
Reducing Arterial Inflammation and Improving Metabolic Health by Dual CCR2 and CCR5 Antagonism in People Living with HIV
通过 CCR2 和 CCR5 双重拮抗作用减少 HIV 感染者的动脉炎症并改善代谢健康
- 批准号:
10475255 - 财政年份:2020
- 资助金额:
$ 22.41万 - 项目类别: